Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Clinical trial NCT04742283 · COMPLETED
Trial details
- NCT number
- NCT04742283
- Sponsor
- Santen Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-17
- Primary completion
- 2021-12-07
- Enrollment
- 323
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.